DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Japan Lifeline Co., Ltd. Manufactures and distributes cardiovascular medical devices, including ablation and diagnostics.	Japan	7575
Japan Medical Dynamic Marketing, INC. Develops & sells orthopedic trauma, joint, and spine implants for hospitals primarily in Japan.	Japan	7600
Jin Medical International Ltd. Designs and manufactures wheelchairs, mobility aids, and rehabilitation devices for personal care.	United States of America	ZJYL
JMS CO.,LTD. Global manufacturer of medical devices for infusion, dialysis, surgery, and cardiovascular therapies.	Japan	7702
JMT CO.,Ltd. Medical devices for orthopedics & neurosurgery, specializing in pain, spine, and knee solutions.	South Korea	094970
Kitazato Corporation Develops and manufactures medical devices and biotech for the entire assisted reproduction cycle.	Japan	368A
KORU Medical Systems, Inc. Develops large-volume subcutaneous drug delivery systems for home & specialty infusion markets.	United States of America	KRMD
Kuros Biosciences Ltd. Biologic tech for predictable spinal fusions, featuring the MagnetOs bone graft.	Switzerland	KURN
LAMEDITECH Co., Ltd. Develops advanced laser devices for medical, beauty, and veterinary applications worldwide.	South Korea	462510
L&C BIO Co., Ltd Develops tissue grafts, medical devices, and cosmetics for tissue regeneration medicine.	South Korea	290650